0001062993-24-003326.txt : 20240215 0001062993-24-003326.hdr.sgml : 20240215 20240215172405 ACCESSION NUMBER: 0001062993-24-003326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laing Lance G. CENTRAL INDEX KEY: 0001716041 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38207 FILM NUMBER: 24644919 MAIL ADDRESS: STREET 1: C/O CELCUITY, 16305 36TH AVENUE N. STREET 2: #450 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celcuity Inc. CENTRAL INDEX KEY: 0001603454 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 BUSINESS PHONE: 763-392-0767 MAIL ADDRESS: STREET 1: 16305 36TH AVENUE N STREET 2: SUITE 100 CITY: MINNEAPOLIS STATE: MN ZIP: 55446 FORMER COMPANY: FORMER CONFORMED NAME: Celcuity LLC DATE OF NAME CHANGE: 20140324 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-02-13 0001603454 Celcuity Inc. CELC 0001716041 Laing Lance G. 16305 36TH AVENUE N. SUITE 100 MINNEAPOLIS MN 55446 1 1 0 0 Chief Science Officer 0 Common Stock 1250000 D Stock Option (right to buy) 8.4000 2027-05-17 Common Stock 16125 16125 D Stock Option (right to buy) 5.50 2027-09-19 Common Stock 4110 4110 D Stock Option (right to buy) 5.50 2028-10-17 Common Stock 1834 1834 D Stock Option (right to buy) 5.50 2029-08-12 Common Stock 50000 50000 D Stock Option (right to buy) 5.9000 2030-08-12 Common Stock 20000 20000 D Stock Option (right to buy) 5.50 2030-12-28 Common Stock 2771 2771 D Stock Option (right to buy) 5.50 2031-02-02 Common Stock 3215 3215 D Stock Option (right to buy) 5.50 2031-03-18 Common Stock 2973 2973 D Stock Option (right to buy) 5.50 2031-04-12 Common Stock 6754 6754 D Stock Option (right to buy) 5.50 2031-08-11 Common Stock 20000 20000 D Stock Option (right to buy) 5.50 2031-10-27 Common Stock 1877 1877 D Stock Option (right to buy) 5.50 2032-05-17 Common Stock 38412 38412 D Stock Option (right to buy) 11.55 2033-02-16 Common Stock 9156 9156 D Stock Option (right to buy) 9.89 2033-08-25 Common Stock 21250 21250 D Stock Option (right to buy) 9.89 2033-08-25 Common Stock 125000 125000 D Stock Option (right to buy) 15.03 2024-02-13 4 A 0 7765 0 A 2034-02-13 Common Stock 7765 7765 D Fully vested. 5,000 shares vest on 8/12/21; the remaining 15,000 shares vest 1/36th per month thereafter. 692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter. 803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter. 743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter. 1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter. 5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter. 469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter. These shares vest in equal amounts on the last day of each month over seventeen (17) months, beginning August 31, 2023. 31,250 shares vest on 8/25/24; the remaining 93,750 shares vest 1/36th per month thereafter. These shares vest in equal amounts on the first day of each month over twelve (12) months, beginning March 1, 2024. /s/ Eric O. Madson as Attorney-in-Fact for Lance G. Laing pursuant to Power of Attorney previously filed. 2024-02-15